CSI Market
Sign In | Register

Aldeyra Therapeutics Inc (ALDX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ALDX Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Aldeyra Therapeutics Inc adapts its asset base and funding mix.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ALDX/balance-sheets
https://api.csimarket.com/api/v1/companies/ALDX/fundamentals
https://api.csimarket.com/api/v1/companies/ALDX/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments0.00
Other Current Assets40.11
Prepaid Expense And Other Assets Current2.81
Total Current Assets42.92
Equipment/Property/Plant Net0.02
Other Assets, Noncurrent0.45
Cash And Money Market Funds65.00
Total Assets43.38
Liabilities
Accounts Payable, Current AC0.14
Accrued Liabilities, Current AC1.56
Long-term Debt, Current Maturities LO0.00
Deferred Revenue, Current DE0.00
Total Current Liabilities7.88
Total Long-term Debt0.00
Deferred Long-term Liability Charges DE6.00
Other liabilities, Noncurrent0.46
OperatingLeaseLiabilityNoncurrent-
Operating Lease Liability Current0.21
Total Liabilities8.16
Stockholders' Equity
Common Stock Value0.06
Additional Paid In Capital Common Stock531.78
Retained Earnings / Accumulated Deficit-496.62
Other Equity0.00
Common Stockholder's Equity35.22
Total Stockholder's Equity35.22
Liabilities & Stockholder's Equity43.38
4 historic quarters locked

Sign in to unlock the full Aldeyra Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Aldeyra Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-449742

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI